Our findings imply that treatment of cardiovascular conditions with ACE inhibitors may have an impact on survival in ovarian cancer patients; however, further studies in larger cohorts and randomised trials are needed to confirm this result. The gene discussed is ACE; the disease is ovarian cancer.